At a glance
- Originator Shionogi
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoplasma infections
Most Recent Events
- 30 Jun 1998 Discontinued-Preclinical for Mycoplasma infections in Japan (Unknown route)
- 13 May 1998 Investigation in Mycoplasma infections in Japan (Unknown route)